Maven Securities LTD Black Diamond Therapeutics, Inc. Transaction History

Maven Securities LTD

  • $774 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 04, 2023
BUY
$1.43 - $6.18 $268,143 - $1.16 Million
187,513 New
187,513 $946,000
Q2 2021

Aug 16, 2021
SELL
$12.19 - $28.17 $609,500 - $1.41 Million
-50,000 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$22.23 - $34.75 $655,785 - $1.03 Million
29,500 Added 143.9%
50,000 $1.18 Million
Q4 2020

Feb 12, 2021
BUY
$29.47 - $35.0 $604,135 - $717,500
20,500 New
20,500 $664,000

Others Institutions Holding BDTX

# of Institutions
117
Shares Held
48.8M
Call Options Held
1.84M
Put Options Held
1.93M
View Full List

About Black Diamond Therapeutics, Inc.

BDTX Quotes by TradingView
  • Ticker BDTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,339,500
  • Market Cap $95.9M
  • Description
  • Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...
More about BDTX
Track This Portfolio

Track Maven Securities LTD Portfolio

Follow Maven Securities LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maven Securities LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email